Aeterna Zentaris to Present at 2017 Marcum MicroCap Conference
June 09 2017 - 08:30AM
Business Wire
Aeterna Zentaris Inc. (TSX: AEZS) (NASDAQ: AEZS) (the “Company”)
today announced that the Company's President and Chief Executive
Officer, David Dodd, will present a corporate overview at the 2017
Marcum MicroCap Conference on Friday, June 16, 2017 at 9:30 a.m.
(Eastern) in New York City. A copy of the presentation will be
available on the Company’s website at www.aezsinc.com.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel pharmaceutical
therapies. We are engaged in drug development activities and in the
promotion of products for others. We recently completed Phase 3
studies of two internally developed compounds. The focus of our
business development efforts is the acquisition of licenses to
products that are relevant to our therapeutic areas of focus. We
also intend to license out certain commercial rights of internally
developed products to licensees in non-U.S. territories where such
out-licensing would enable us to ensure development, registration
and launch of our product candidates. Our goal is to become a
growth-oriented specialty biopharmaceutical company by pursuing
successful development and commercialization of our product
portfolio, achieving successful commercial presence and growth,
while consistently delivering value to our shareholders, employees
and the medical providers and patients who will benefit from our
products. For more information, visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170609005008/en/
Aeterna ZentarisPhilip A. Theodore, 843-900-3223Senior Vice
Presidentir@aezsinc.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2023 to Mar 2024